Published in Lancet on May 20, 2000
Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet (1998) 4.33
Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke (2001) 3.90
Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg (2000) 3.83
Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology (2006) 2.46
SSEPs and prognosis in postanoxic coma: only short or also long latency responses? Neurology (2006) 2.31
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03
Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry (2001) 1.84
Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology (2008) 1.80
Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology (2007) 1.79
Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet (1999) 1.67
[Prognosis for patients in a coma following cardiopulmonary resuscitation]. Ned Tijdschr Geneeskd (2008) 1.60
Handicap questionnaires: what do they assess? Disabil Rehabil (1999) 1.60
Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology (2004) 1.58
Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost (1997) 1.56
Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia (2004) 1.56
The development of a handicap assessment questionnaire: the Impact on Participation and Autonomy (IPA). Clin Rehabil (1999) 1.51
Psychometric properties of the Impact on Participation and Autonomy Questionnaire. Arch Phys Med Rehabil (2001) 1.50
Morbidity and mortality following pallidotomy in Parkinson's disease: a systematic review. Neurology (2002) 1.47
Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med (1984) 1.46
Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann Neurol (1985) 1.44
The burden of caregiving in partners of long-term stroke survivors. Stroke (1998) 1.41
[Vascular brain damage: an important and recognizable cause of cognitive and behavioral disorders]. Ned Tijdschr Geneeskd (1999) 1.39
[Current diagnostic criteria for vascular dementia; milestone or obstacle?]. Ned Tijdschr Geneeskd (1993) 1.38
Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol (2002) 1.32
Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry (2000) 1.26
Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke (1989) 1.26
Wound healing in cell studies and animal model experiments by Low Level Laser Therapy; were clinical studies justified? a systematic review. Lasers Med Sci (2002) 1.25
What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol (2008) 1.21
Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke (1997) 1.21
The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting. Eur J Cancer (2004) 1.18
Systematic review of prediction of poor outcome in anoxic-ischaemic coma with biochemical markers of brain damage. Intensive Care Med (2001) 1.17
Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol (1985) 1.16
The role of cognitive impairment in the quality of life after ischaemic stroke. J Neurol (1996) 1.15
Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis (2000) 1.13
The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology (2007) 1.12
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: clinicoanatomic correlations. Neurology (1986) 1.10
Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up. J Neurol Neurosurg Psychiatry (2006) 1.09
Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice. Br J Cancer (2003) 1.08
Posttraumatic stress symptoms in adult survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.07
TIA, RIND, minor stroke: a continuum, or different subgroups? Dutch TIA Study Group. J Neurol Neurosurg Psychiatry (1992) 1.04
Measuring quality of life in children with inflammatory bowel disease: the impact-II (NL). Qual Life Res (2002) 1.04
Interobserver and intraobserver reproducibility of peripheral blood and oxygen pressure measurements in the assessment of lower extremity arterial disease. J Vasc Surg (2001) 1.01
Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage. J Neurosurg (1985) 1.01
Interobserver variation in the interpretation of SSEPs in anoxic-ischaemic coma. Clin Neurophysiol (2006) 1.01
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology (2004) 1.01
Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke (1998) 1.01
Quality of survival after cardiopulmonary resuscitation. Arch Intern Med (1999) 0.98
Comparison of maximal voluntary isometric contraction and hand-held dynamometry in measuring muscle strength of patients with progressive lower motor neuron syndrome. Neuromuscul Disord (2003) 0.98
No excess fatigue in young adult survivors of childhood cancer. Eur J Cancer (2003) 0.97
A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30). Stroke (1997) 0.97
Somatosensory evoked potentials during mild hypothermia after cardiopulmonary resuscitation. Neurology (2009) 0.96
The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg (1990) 0.96
Predicting survival in patients with early Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 0.96
Enlargement of the third ventricle and hyponatraemia in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1988) 0.95
Risk factors for falls of hospitalized stroke patients. Stroke (1997) 0.95
Rerupture of intracranial aneurysms: a clinicoanatomic study. J Neurosurg (1987) 0.95
Impact of survival probability, life expectancy, quality of life and patient preferences on do-not-attempt-resuscitation orders in a hospital. Resuscitation Committee. Resuscitation (1999) 0.92
Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord (2010) 0.92
Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomised clinical trial. Lasers Med Sci (2003) 0.92
Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke (1989) 0.91
Direct costs of modern treatment of aneurysmal subarachnoid hemorrhage in the first year after diagnosis. Stroke (2002) 0.91
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography. Clin Neurol Neurosurg (1993) 0.90
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy. Neurology (2011) 0.90
Bacterial contamination of ready-to-use 1-L feeding bottles and administration sets in severely compromised intensive care patients. Crit Care Med (2000) 0.89
Patients' satisfaction with care after stroke: relation with characteristics of patients and care. Qual Health Care (1996) 0.88
Decisions to terminate resuscitation. Resuscitation Committee. Resuscitation (1999) 0.88
Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology (2000) 0.87
Diagnosis of Alzheimer's disease by apolipoprotein E genotyping. Lancet (1994) 0.87
Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136. Stroke (2000) 0.87
A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial. Trials (2010) 0.86
Brain infarcts in adults with bacterial meningitis. Lancet (1996) 0.85
[New therapies in neurology, but who benefits?]. Ned Tijdschr Geneeskd (1999) 0.85
Number of nursing staff and falls: a case-control study on falls by stroke patients in acute-care settings. J Adv Nurs (1993) 0.85
Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J Neurol Neurosurg Psychiatry (1991) 0.85
Silent stroke in patients with transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. Stroke (1992) 0.84
Prediction of poor outcome in anoxic-ischemic coma. J Clin Neurophysiol (2000) 0.84
Prognostic factors for ambulation and activities of daily living in the subacute phase after stroke. A systematic review of the literature. Clin Rehabil (2003) 0.84
Impact of stroke type on survival and functional health. Cerebrovasc Dis (2001) 0.84
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson's disease: one year follow-up of a randomised observer-blind multi centre trial. Acta Neurochir (Wien) (2006) 0.83
Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial. Cerebrovasc Dis (2009) 0.83
The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial. Pediatr Hematol Oncol (2002) 0.82
Prognostic factors in the subacute phase after stroke for the future residence after six months to one year. A systematic review of the literature. Clin Rehabil (2003) 0.81
Causes of acute deterioration in patients with a ruptured intracranial aneurysm. A prospective study with serial CT scanning. J Neurosurg (1984) 0.81
The usefulness of a laser Doppler in the measurement of toe blood pressures. J Vasc Surg (2000) 0.80
Mental changes in subcortical arteriosclerotic encephalopathy. Clin Neurol Neurosurg (1987) 0.80
[CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]. Tijdschr Gerontol Geriatr (1991) 0.80
Quantitative spectral electroencephalography in predicting survival in patients with early Alzheimer disease. Arch Neurol (1998) 0.80